Otsuka America Pharmaceutical, Inc. drugs

8 results
  • abilify - aripiprazole tablet

    (Aripiprazole)
    Otsuka America Pharmaceutical, Inc.
    Abilify (aripiprazole) is indicated for schizophrenia, acute manic and mixed episodes of Bipolar I Disorder, adjunctive treatment of major depressive disorder, irritability associated with autistic disorder, and Tourette's Disorder.
  • abilify maintena - aripiprazole

    (Aripiprazole)
    Otsuka America Pharmaceutical, Inc.
    Abilify Maintena (aripiprazole) is an injectable antipsychotic indicated for treating schizophrenia in adults and for maintenance monotherapy treatment of bipolar I disorder in adults.
  • rexulti - brexpiprazole tablet

    (Brexpiprazole)
    Otsuka America Pharmaceutical, Inc.
    REXULTI is used as add-on therapy with antidepressants for major depressive disorder in adults, treats schizophrenia in adults and adolescents 13 and older, and manages agitation from Alzheimer's-related dementia. Not approved for as-needed use.
  • samsca - tolvaptan tablet

    (Tolvaptan)
    Otsuka America Pharmaceutical, Inc.
    Samsca treats clinically significant hypervolemic and euvolemic hyponatremia (low blood sodium) in adults, including those with heart failure or SIADH, when fluid restriction has failed. Not indicated when urgent sodium correction is needed for serious neurological symptoms.